(Q55240139)

28 June 2018

title

Interferon-alpha treatment in a case of HTLV-I-associated myelopathy. (English)

1 reference

28 June 2018

Human T-lymphotropic virus 1

main subject

0 references

author name string

Porta-Etessam J

series ordinal

1

1 reference

28 June 2018

Molina JA

series ordinal

2

1 reference

28 June 2018

Bermejo F

series ordinal

3

1 reference

28 June 2018

publication date

1 September 1998

1 reference

28 June 2018

European Journal of Neurology

published in

1 reference

28 June 2018

volume

5

1 reference

28 June 2018

page(s)

515

1 reference

28 June 2018

issue

5

1 reference

28 June 2018

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.550515.X

Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.550515.X

Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.550515.X

Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.550515.X

10.1046/J.1468-1331.1998.550515.X

21 January 2018

Identifiers

DOI

1 reference

28 June 2018

PubMed ID

10210884

1 reference

28 June 2018